NCT03240575 · Interventional trial
The ENERGITO® 2 Study Compares 2 Inhaled Medicines for Chronic Obstructive Pulmonary Disease (COPD). One Medicine is a Combination of Tiotropium and Olodaterol (Stiolto®) Taken Using the Respimat® Inhaler and the Other Medicine is a Combination of Fluticasone and Salmeterol Taken Using the Diskus
Overall registry status Completed
Phase 4
Conditions Pulmonary Disease, Chronic Obstructive
Delaware Valley sites
- Arcuri Clinical Research, LLC · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory